Stay updated on APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The clinical trial record for a study of APX005M-based combinations in previously untreated metastatic pancreatic cancer is now displayed, including study design, eligibility criteria, outcomes, and supporting documents.
    Difference
    70%
    Check dated 2026-11-08T23:57:04.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0, with the study page still showing a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T23:56:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T23:40:29.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T00:12:54.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:54:51.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the site header, navigation, and a revision footer. The extensive list of study documents and related metadata that previously appeared on the page is no longer shown.
    Difference
    21%
    Check dated 2026-09-20T22:54:33.000Z thumbnail image

Stay in the know with updates to APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.